Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gadolinium × Genitourinary × Clear all

Phase

Status

Unknown 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 31 Radiosurgery 23 Radiotherapy 21 Sunitinib 20 pembrolizumab 18 Gemcitabine 17 Cisplatin 17 Androgen Antagonists 16 Nivolumab 14 enzalutamide 13 Surveys and Questionnaires 12 aldesleukin 11 Prednisone 11 Leuprolide 11 Goserelin 11 Cyclophosphamide 11 Blood Specimen Collection 11 Abiraterone Acetate 11 Carboplatin 10 Bevacizumab 10 bicalutamide 9 Multiparametric Magnetic Resonance Imaging 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 Gonadotropin-Releasing Hormone 8 Filgrastim 8 Epirubicin 8 Chemotherapy, Adjuvant 8 Brachytherapy 8 toripalimab 7 tislelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01562223 2021-10-18

A6701QIBA

American College of Radiology Imaging Network

Phase NA Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡